Nanoformulations of Anticancer FGFR Inhibitors with Improved Therapeutic Index

Fibroblast growth factor receptor (FGFR) inhibitors like ponatinib and nintedanib are clinically approved for defined cancer patient cohorts but often exert dose-limiting adverse effects. Hence, we encapsulated FGFR inhibitors ponatinib, PD173074, and nintedanib into polylactic acid nanoparticles an...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Nanomedicine
Main Authors: Kallus, Sebastian, Englinger, Bernhard, Senkiv, Julia, Laemmerer, Anna, Heffeter, Petra, Berger, Walter, Kowol, Christian R., Keppler, Bernhard K.
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611408/
https://ncbi.nlm.nih.gov/pubmed/30121385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2018.08.001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker